Tech Company Financing Transactions

OccuLogix Funding Round

OccuLogix closed a $1.7 million financing round on 1/21/2010. Backers included private investors.

Transaction Overview

Company Name
Announced On
1/21/2010
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
11025 Roselle St 100
San Diego, CA 92121
USA
Email Address
Overview
TearLab Corporation is an in-vitro diagnostics company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Profile
OccuLogix LinkedIn Company Profile
Social Media
OccuLogix Company Twitter Account
Company News
OccuLogix News
Facebook
OccuLogix on Facebook
YouTube
OccuLogix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Elias Vamvakas
  Elias Vamvakas LinkedIn Profile  Elias Vamvakas Twitter Account  Elias Vamvakas News  Elias Vamvakas on Facebook
Chief Financial Officer
William Dumencu
  William Dumencu LinkedIn Profile  William Dumencu Twitter Account  William Dumencu News  William Dumencu on Facebook
Chief Medical Officer
Michael Lemp
  Michael Lemp LinkedIn Profile  Michael Lemp Twitter Account  Michael Lemp News  Michael Lemp on Facebook
Chief Scientific Officer
Benjamin Sullivan
  Benjamin Sullivan LinkedIn Profile  Benjamin Sullivan Twitter Account  Benjamin Sullivan News  Benjamin Sullivan on Facebook
VP - Manufacturing
Steve Zmina
  Steve Zmina LinkedIn Profile  Steve Zmina Twitter Account  Steve Zmina News  Steve Zmina on Facebook
VP - Marketing
Tracy Puckett
  Tracy Puckett LinkedIn Profile  Tracy Puckett Twitter Account  Tracy Puckett News  Tracy Puckett on Facebook
VP - Operations
Bob Walder
  Bob Walder LinkedIn Profile  Bob Walder Twitter Account  Bob Walder News  Bob Walder on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/20/2010: Kolltan Pharmaceuticals venture capital transaction
Next: 1/21/2010: Bluesocket venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary